Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.
about
Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer.Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapyA Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate CancerBeyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
P2860
Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antitumor effects of carnertin ...... parative study with erlotinib.
@en
Antitumor effects of carnertin ...... parative study with erlotinib.
@nl
type
label
Antitumor effects of carnertin ...... parative study with erlotinib.
@en
Antitumor effects of carnertin ...... parative study with erlotinib.
@nl
prefLabel
Antitumor effects of carnertin ...... parative study with erlotinib.
@en
Antitumor effects of carnertin ...... parative study with erlotinib.
@nl
P2093
P2860
P50
P356
P1433
P1476
Antitumor effects of carnertin ...... parative study with erlotinib.
@en
P2093
Claudio Festuccia
Corrado Ficorella
Leda Biordi
Marcella Motta
Margherita Piccolella
Vincenzo Tombolini
P2860
P304
P356
10.1002/PROS.21363
P577
2011-03-28T00:00:00Z